Safety of hydroxychloroquine for treatment or prevention of SARS‐CoV‐2 infection: A rapid systematic review and meta‐analysis of randomized clinical trials

Safety of hydroxychloroquine for treatment or prevention of SARS‐CoV‐2 infection: A rapid systematic review and meta‐analysis of randomized clinical trials

Abstract Introduction Hydroxycloroquine (HCQ) has been extensively studied for treatment and prevention of coronavirus diseases 2019 (COVID‐19) from the start of the pandemic. Conflicting evidence about its usefulness has begun to accrue. Methods In the face of controversial results about clinical e...

Full description

Bibliographic Details
Main Authors: Alberto Enrico Maraolo, Adriano Grossi
Format: Article
Language:English
Published: Wiley 2021-03-01
Series:Immunity, Inflammation and Disease
Subjects:
COVID‐19
hydroxychloroquine
meta‐analysis
randomized controlled trials
safety
SARS‐CoV‐2
Online Access:https://doi.org/10.1002/iid3.374

Internet

https://doi.org/10.1002/iid3.374

Similar Items